Recent News filter by Type: All PORTFOLIO NEWS AVALON NEWS PORTFOLIO NEWS Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases September 02, 2025 PORTFOLIO NEWS AeroRx Therapeutics Announces Topline Positive Phase 2a Data for Inhaled AERO-007, the First Nebulized LABA/LAMA Combination in Development for COPD July 30, 2025 PORTFOLIO NEWS Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease June 17, 2025 PORTFOLIO NEWS Arialys Therapeutics Initiates MAD Cohorts Having Completed All Planned SAD Cohorts in a Phase 1 Study of ART5803 for the Treatment of Autoimmune Neuropsychiatric Disease February 26, 2025 PORTFOLIO NEWS Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC December 02, 2024 PORTFOLIO NEWS Valora Therapeutics Raises $30 Million Seed Financing November 20, 2024 PORTFOLIO NEWS Enlaza Therapeutics marries covalent and biologic drugs November 08, 2024 PORTFOLIO NEWS Arialys Therapeutics Announces First Participants Dosed in a Phase 1 Clinical Trial of ART5803, a Precision Medicine for the Treatment of Autoimmune Neuropsychiatric Diseases October 10, 2024 PORTFOLIO NEWS A Biotech Dousing ‘Fires’ in the Brain that Plagued a Bestselling Author August 08, 2024 1 2